244 related articles for article (PubMed ID: 22185458)
1. Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα.
Xing B; Bachstetter AD; Van Eldik LJ
Mol Neurodegener; 2011 Dec; 6():84. PubMed ID: 22185458
[TBL] [Abstract][Full Text] [Related]
2. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ).
Bachstetter AD; Xing B; de Almeida L; Dimayuga ER; Watterson DM; Van Eldik LJ
J Neuroinflammation; 2011 Jul; 8():79. PubMed ID: 21733175
[TBL] [Abstract][Full Text] [Related]
3. Deficiency in p38β MAPK fails to inhibit cytokine production or protect neurons against inflammatory insult in in vitro and in vivo mouse models.
Xing B; Bachstetter AD; Van Eldik LJ
PLoS One; 2013; 8(2):e56852. PubMed ID: 23457629
[TBL] [Abstract][Full Text] [Related]
4. The p38α MAPK regulates microglial responsiveness to diffuse traumatic brain injury.
Bachstetter AD; Rowe RK; Kaneko M; Goulding D; Lifshitz J; Van Eldik LJ
J Neurosci; 2013 Apr; 33(14):6143-53. PubMed ID: 23554495
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neuronal p38α, but not p38β MAPK, provides neuroprotection against three different neurotoxic insults.
Xing B; Bachstetter AD; Van Eldik LJ
J Mol Neurosci; 2015 Feb; 55(2):509-18. PubMed ID: 25012593
[TBL] [Abstract][Full Text] [Related]
6. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present.
Li J; Ramenaden ER; Peng J; Koito H; Volpe JJ; Rosenberg PA
J Neurosci; 2008 May; 28(20):5321-30. PubMed ID: 18480288
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt.
Xing B; Xin T; Hunter RL; Bing G
J Neuroinflammation; 2008 Jan; 5():4. PubMed ID: 18205920
[TBL] [Abstract][Full Text] [Related]
9. Deletion of p38α MAPK in microglia blunts trauma-induced inflammatory responses in mice.
Morganti JM; Goulding DS; Van Eldik LJ
J Neuroinflammation; 2019 May; 16(1):98. PubMed ID: 31077217
[TBL] [Abstract][Full Text] [Related]
10. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease.
Culbert AA; Skaper SD; Howlett DR; Evans NA; Facci L; Soden PE; Seymour ZM; Guillot F; Gaestel M; Richardson JC
J Biol Chem; 2006 Aug; 281(33):23658-67. PubMed ID: 16774924
[TBL] [Abstract][Full Text] [Related]
11. Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice.
Tanaka S; Ishii A; Ohtaki H; Shioda S; Yoshida T; Numazawa S
J Neuroinflammation; 2013 Dec; 10():143. PubMed ID: 24289537
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide preconditioning induces protection against lipopolysaccharide-induced neurotoxicity in organotypic midbrain slice culture.
Ding Y; Li L
Neurosci Bull; 2008 Aug; 24(4):209-18. PubMed ID: 18668149
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia.
Noda M; Kariura Y; Pannasch U; Nishikawa K; Wang L; Seike T; Ifuku M; Kosai Y; Wang B; Nolte C; Aoki S; Kettenmann H; Wada K
J Neurochem; 2007 Apr; 101(2):397-410. PubMed ID: 17402969
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.
Qin L; Liu Y; Wang T; Wei SJ; Block ML; Wilson B; Liu B; Hong JS
J Biol Chem; 2004 Jan; 279(2):1415-21. PubMed ID: 14578353
[TBL] [Abstract][Full Text] [Related]
16. The p38alpha mitogen-activated protein kinase limits the CNS proinflammatory cytokine response to systemic lipopolysaccharide, potentially through an IL-10 dependent mechanism.
Bachstetter AD; Xing B; Van Eldik LJ
J Neuroinflammation; 2014 Oct; 11():175. PubMed ID: 25297465
[TBL] [Abstract][Full Text] [Related]
17. CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.
Zhu Y; Hou H; Nikolic WV; Ehrhart J; Rrapo E; Bickford P; Giunta B; Tan J
PLoS One; 2008 May; 3(5):e2135. PubMed ID: 18478117
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures.
Zhu Y; Chen X; Liu Z; Peng YP; Qiu YH
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729090
[TBL] [Abstract][Full Text] [Related]
19. Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity.
Shie FS; Montine KS; Breyer RM; Montine TJ
Glia; 2005 Oct; 52(1):70-7. PubMed ID: 15920732
[TBL] [Abstract][Full Text] [Related]
20. Gö6976 inhibits LPS-induced microglial TNFalpha release by suppressing p38 MAP kinase activation.
Jeohn GH; Cooper CL; Jang KJ; Liu B; Lee DS; Kim HC; Hong JS
Neuroscience; 2002; 114(3):689-97. PubMed ID: 12220570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
